Pragna Patel1, Charles E Rose2, Pamela Y Collins3, Bernardo Nuche-Berenguer4, Vikrant V Sahasrabuddhe5, Emmanuel Peprah6, Susan Vorkoper7, Sonak D Pastakia8, Dianne Rausch9, Naomi S Levitt10. 1. Center for Global Health. 2. National Center on Birth Defects & Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. University of Washington, Department of Psychiatry and Behavioral Sciences and Department of Global Health. 4. National Institute of Diabetes and Digestive and Kidney Diseases. 5. National Cancer Institute. 6. National Heart, Lung, and Blood Institute. 7. Fogarty International Center, National Institutes of Health, Bethesda, Maryland. 8. Purdue University College of Pharmacy, West Lafayette, Indiana, USA. 9. National Institute of Mental Health, National Institutes of Health. 10. Department of Medicine, University of Cape Town, Cape Town, South Africa.
Abstract
OBJECTIVE: To appropriately identify and treat noncommunicable diseases (NCDs) among persons living with HIV (PLHIV) in low-and-middle-income countries (LMICs), it is imperative to understand the burden of NCDs among PLHIV in LMICs and the current management of the diseases. DESIGN: Systematic review and meta-analysis. METHODS: We examined peer-reviewed literature published between 1 January 2010 and 31 December 2016 to assess currently available evidence regarding HIV and four selected NCDs (cardiovascular disease, cervical cancer, depression, and diabetes) in LMICs with a focus on sub-Saharan Africa. The databases, PubMed/MEDLINE, Cochrane Review, and Scopus, were searched to identify relevant literature. For conditions with adequate data available, pooled estimates for prevalence were generated using random fixed effects models. RESULTS: Six thousand one hundred and forty-three abstracts were reviewed, 377 had potentially relevant prevalence data and 141 were included in the summary; 57 were selected for quantitative analysis. Pooled estimates for NCD prevalence were hypertension 21.2% (95% CI 16.3-27.1), hypercholesterolemia 22.2% (95% CI 14.7-32.1), elevated low-density lipoprotein 23.2% (95% CI 15.2-33.6), hypertriglyceridemia 27.2% (95% CI 20.7-34.8), low high-density lipoprotein 52.3% (95% CI 35.6-62.8), obesity 7.8% (95% CI 4.3-13.9), and depression 24.4% (95% CI 12.5-42.1). Invasive cervical cancer and diabetes prevalence were 1.3-1.7 and 1.3-18%, respectively. Few NCD-HIV integrated programs with screening and management approaches that are contextually appropriate for resource-limited settings exist. CONCLUSION: Improved data collection and surveillance of NCDs among PLHIV in LMICs are necessary to inform integrated HIV/NCD care models. Although efforts to integrate care exist, further research is needed to optimize the efficacy of these programs.
OBJECTIVE: To appropriately identify and treat noncommunicable diseases (NCDs) among persons living with HIV (PLHIV) in low-and-middle-income countries (LMICs), it is imperative to understand the burden of NCDs among PLHIV in LMICs and the current management of the diseases. DESIGN: Systematic review and meta-analysis. METHODS: We examined peer-reviewed literature published between 1 January 2010 and 31 December 2016 to assess currently available evidence regarding HIV and four selected NCDs (cardiovascular disease, cervical cancer, depression, and diabetes) in LMICs with a focus on sub-Saharan Africa. The databases, PubMed/MEDLINE, Cochrane Review, and Scopus, were searched to identify relevant literature. For conditions with adequate data available, pooled estimates for prevalence were generated using random fixed effects models. RESULTS: Six thousand one hundred and forty-three abstracts were reviewed, 377 had potentially relevant prevalence data and 141 were included in the summary; 57 were selected for quantitative analysis. Pooled estimates for NCD prevalence were hypertension 21.2% (95% CI 16.3-27.1), hypercholesterolemia 22.2% (95% CI 14.7-32.1), elevated low-density lipoprotein 23.2% (95% CI 15.2-33.6), hypertriglyceridemia 27.2% (95% CI 20.7-34.8), low high-density lipoprotein 52.3% (95% CI 35.6-62.8), obesity 7.8% (95% CI 4.3-13.9), and depression 24.4% (95% CI 12.5-42.1). Invasive cervical cancer and diabetes prevalence were 1.3-1.7 and 1.3-18%, respectively. Few NCD-HIV integrated programs with screening and management approaches that are contextually appropriate for resource-limited settings exist. CONCLUSION: Improved data collection and surveillance of NCDs among PLHIV in LMICs are necessary to inform integrated HIV/NCD care models. Although efforts to integrate care exist, further research is needed to optimize the efficacy of these programs.
Authors: Matthys Cornelis van Aardt; Greta Dreyer; Hannelie Francina Pienaar; Frank Karlsen; Siri Hovland; Karin Louise Richter; Piet Becker Journal: Int J Gynecol Cancer Date: 2015-06 Impact factor: 3.437
Authors: P G Motti; G A Dallabetta; R W Daniel; J K Canner; J D Chiphangwi; G N Liomba; L Yang; K V Shah Journal: J Infect Dis Date: 1996-03 Impact factor: 5.226
Authors: Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren Journal: N Engl J Med Date: 2007-04-26 Impact factor: 91.245
Authors: Stephanie V Wrottesley; Lisa K Micklesfield; Matthew M Hamill; Gail R Goldberg; Ann Prentice; John M Pettifor; Shane A Norris; Alison B Feeley Journal: Public Health Nutr Date: 2013-07-09 Impact factor: 4.022
Authors: V V Sahasrabuddhe; M H Mwanahamuntu; S H Vermund; W K Huh; M D Lyon; J S A Stringer; G P Parham Journal: Br J Cancer Date: 2007-04-17 Impact factor: 7.640
Authors: Signe W Worm; Stephane De Wit; Rainer Weber; Caroline A Sabin; Peter Reiss; Wafaa El-Sadr; Antonella D'Arminio Monforte; Ole Kirk; Eric Fontas; Francois Dabis; Matthew G Law; Jens D Lundgren; Nina Friis-Møller Journal: Circulation Date: 2009-02-02 Impact factor: 39.918
Authors: Susan Vorkoper; Linda E Kupfer; Nalini Anand; Pragna Patel; Blythe Beecroft; William M Tierney; Robert Ferris; Wafaa M El-Sadr Journal: AIDS Date: 2018-07-01 Impact factor: 4.177
Authors: Michael J A Reid; Yifei Ma; Iya Golovaty; Samson Okello; Ruth Sentongo; Maggie Feng; Alexander C Tsai; Bernard Kakuhikire; Russell Tracy; Peter W Hunt; Mark Siedner; Phyllis C Tien Journal: AIDS Patient Care STDS Date: 2019-06-12 Impact factor: 5.078
Authors: Gabriel Chamie; Matthew D Hickey; Dalsone Kwarisiima; James Ayieko; Moses R Kamya; Diane V Havlir Journal: Curr HIV/AIDS Rep Date: 2020-08 Impact factor: 5.071
Authors: Martin Muddu; Andrew K Tusubira; Srish K Sharma; Ann R Akiteng; Isaac Ssinabulya; Jeremy I Schwartz Journal: J Acquir Immune Defic Syndr Date: 2019-08-15 Impact factor: 3.731
Authors: Preeti Manavalan; Linda Minja; Lisa Wanda; Julian T Hertz; Nathan M Thielman; Nwora Lance Okeke; Blandina T Mmbaga; Melissa H Watt Journal: PLoS One Date: 2020-12-03 Impact factor: 3.240
Authors: Brianna Osetinsky; Becky L Genberg; Gerald S Bloomfield; Joseph Hogan; Sonak Pastakia; Edwin Sang; Anthony Ngressa; Ann Mwangi; Mark N Lurie; Stephen T McGarvey; Omar Galárraga Journal: J Acquir Immune Defic Syndr Date: 2019-12-01 Impact factor: 3.731